DISEASE SCANNER
Global Incurable Diseases Tracker
Duchenne Muscular Dystrophy (DMD)
An X-linked recessive disorder caused by mutations in the DMD gene encoding dystrophin, essential for muscle fiber integrity. Primarily affects males (1 in 3,500-5,000 male births), causing progressive muscle degeneration and weakness.
250.0K
15
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Genetic testing
- 2Clinical evaluation
- 3Family history assessment
- 4Specialized laboratory tests
- 5Imaging studies
- 6Biopsy (if applicable)
Prognosis
Progressive muscle weakness. Loss of ambulation by age 12 without steroids, 16 with steroids. Respiratory and cardiac involvement in late teens. Death typically in 20s-30s from cardiac or respiratory failure. Newer therapies extending lifespan.
Prevention
- Genetic counseling
- Carrier screening
- Prenatal diagnosis
- Preimplantation genetic diagnosis
- Family planning
Research Status
Exon-skipping drugs (Exondys 51, Vyondys 53, Amondys 45) approved. Gene therapy (Elevidys) FDA-approved. CRISPR clinical trials ongoing. Corticosteroids extend ambulation.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books/NBK1116
- https://medlineplus.gov/genetics
- https://rarediseases.org
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.